D-0891-2023 Class II Terminated
FDA drug recall D-0891-2023 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on May 30, 2023 and is designated Class II. Reason for recall: Subpotent drug The recall status is terminated (terminated Dec 18, 2023). Affected quantity: 12960 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 5, 2023
- Initiation Date
- May 30, 2023
- Termination Date
- Dec 18, 2023
- Product Quantity
- 12960 vials
Product description
Amphotericin B Liposome for Injection, 50mg/vial, Rx only, Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti, Halol-389350, Gujarat, India, NDC 62756-0233-01
Reason for recall
Subpotent drug
Distribution pattern
USA nationwide
Code information
Lot # BAD0089A, Exp 01/2025; BAD0330A, Exp 07/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0891-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026